zhenhua chemical(SH:603067) Xin Lang Cai Jing·2025-04-29 10:26Core Insights - The company demonstrated operational resilience in a complex market environment, with significant growth in net profit despite a decline in operating cash flow [1] Financial Performance Summary - Revenue showed steady growth, reaching CNY 4,066,719,390.71 in 2024, a 9.95% increase from CNY 3,698,698,929.53 in the previous year, indicating successful market expansion and sales [2] - Net profit attributable to shareholders increased significantly to CNY 472,876,416.35, up 27.53% from CNY 370,808,626.75 in 2023, driven by effective cost control and favorable market conditions [3] - Deducting non-recurring gains, the net profit was CNY 482,269,470.66, reflecting a 26.17% increase from CNY 382,244,672.31, indicating enhanced core business profitability [4] - Basic earnings per share rose to CNY 0.94, a 27.03% increase from CNY 0.74, while the diluted earnings per share increased to CNY 0.96, up 26.32% from CNY 0.76, showcasing improved returns for shareholders [5] Expense Analysis - Sales expenses slightly decreased to CNY 38,054,212.16, a minor drop of 0.02% from CNY 38,060,535.31, indicating stable cost management [6] - Management expenses also saw a slight decline to CNY 265,428,135.66, down 0.51% from CNY 266,793,810.71, reflecting effective administrative cost control [7] - Financial expenses decreased by 12.08% to CNY 28,906,852.36 from CNY 32,880,377.29, likely due to optimized debt structure and increased interest income [8] - Research and development expenses increased to CNY 128,345,946.19, an 11.98% rise from CNY 114,610,064.25, highlighting the company's commitment to innovation and product upgrades [9] Cash Flow Analysis - Operating cash flow net amount decreased by 15.87% to CNY 333,426,615.89 from CNY 396,313,628.35, potentially due to increased cash payments for goods and services or longer accounts receivable collection periods [11] - Investment cash flow net amount was negative at CNY -363,939,933.53, worsening from CNY -274,208,180.24, indicating significant cash outflows for fixed asset acquisitions and capacity expansion [12] - Financing cash flow net amount turned positive at CNY 197,954,308.94, compared to CNY -138,212,278.80 in the previous year, reflecting improved cash inflows from borrowing and reduced debt repayments [13] R&D and Personnel Insights - Total R&D investment was CNY 128,345,946.19, accounting for 3.16% of revenue, emphasizing the importance of technological advancement for future growth [14] - The R&D team consisted of 281 personnel, representing 13.53% of the total workforce, with a stable educational and age structure, ensuring a strong foundation for innovation [15]